Eli Lilly (LLY) traded at $1,429.31, down 1.94% on the day, even after a third-quarter beat and a full-year guidance lift on October 29, 2026. Barclays also raised its price target to $1,550, while… (Read More)Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here